CRISPR Therapeutics AG
Industry: Life Sciences ・ $CRSP on Nasdaq
Insider Sale
+$826,500
-5.32%
Shares
Shares Volume: 15,000 Shares
Average Share Price: $55.1
INSIDER
Kulkarni Samarth
Chief Executive Officer (Director)
reported on Dec 4 2024
traded on Dec 2 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 267,162 |
| PURCHASES/SALES 1Y | 0 / 10 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,284,193.42 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 15 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $919,403.58 |
| COMPANY PREVIOUS TRADES |